Document is current
Any future updates will be listed below
-
Authors
Mastrangelo, Andrea
Caldera, Serena
Baiardi, Simone
Magliocchetti, Franco
Mammana, Angela
Testa, Matilde
Ranieri, Agustina
Ruggeri, Edoardo
Bentivenga, Giuseppe Mario
Mastrangelo, Vincenzo
Mometto, Nicola
Ferri, Caterina
Marti, Alessandro
Santangelo, Mario
Longoni, Marco
Mazzoli, Sara
Chiari, Annalisa
Biscetti, Leonardo
Capellari, Sabina
Parchi, Piero
-
Funding
Funding for this research was provided by:
Ministero dell'Università e della Ricerca (MNESYS (PE0000006))
Ministero della Salute (RF-2021-12374386)
- License Information
-
More Information
Article History
Received: 7 November 2025
Accepted: 26 February 2026
First Online: 6 March 2026
Declarations
:
: The study was conducted in compliance with the revised Declaration of Helsinki for the protection of human participants and Good Clinical Practice guidelines, and was approved by the local ethics committee (approval number AVEC:18025, 113/2018/OSS/AUSLBO). Written informed consent was given by study participants or their next of kin.
: Not applicable.
: C.F. has received travel grants or attended conferences upon invitation from Biogen, Sanofi, Novartis and Alexion and has received speaking honoraria from Novartis, Sanofi and AstraZeneca. The other authors have no competing interests.
